# ClearPoint Neuro, Inc.

> Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.

## Record

| Field | Value |
| --- | --- |
| Representation | alpha-profile-markdown-v4 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| Governance record representation | alpha-governance-record-v2 |
| Canonical entity | alpha:company:0ec501c5-0069-42c7-b1a3-e45364681e9f |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/clearpoint-neuro-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 18 |
| Claims under review | 1 |
| Evidence records | 4 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-10-25T04:46:33.007823+00:00 |
| Last reviewed | 2026-10-25T04:46:33.007823+00:00 |

## Identity

- Legal name: ClearPoint Neuro, Inc.
- Display name: ClearPoint Neuro, Inc.

## Alpha Governance Record

| Field | Value |
| --- | --- |
| Governance Record schema | alpha-governance-record-v2 |
| Ontology | alpha-governance-ontology-v1 |
| Record version | public-1:ro-d751713988987e9331980363e24189ce |
| As of | 2026-10-25T04:46:33.007823+00:00 |
| Completeness | 0.409 |
| Record Quality | 0.815 |
| Directors | 7 |
| Committees | 2 |
| Governance events | 5 |
| Entity class | public_company |

## Section coverage

| Section | State |
| --- | --- |
| identity | PUBLISHED |
| corporate_structure | NOT_REVIEWED |
| board | PUBLISHED |
| committees | PUBLISHED |
| leadership | PUBLISHED |
| ownership | NOT_REVIEWED |
| financials | NOT_REVIEWED |
| capital_structure | PUBLISHED |
| compensation | NOT_REVIEWED |
| governance | NOT_REVIEWED |
| shareholder_governance | NOT_REVIEWED |
| audit | NOT_REVIEWED |
| legal | NOT_REVIEWED |
| risk | NOT_REVIEWED |
| cyber | NOT_REVIEWED |
| ai_governance | NOT_REVIEWED |
| agent_governance | RESTRICTED |
| markets_external | NOT_REVIEWED |
| events | PUBLISHED |
| relationships | PUBLISHED |
| assessments | PUBLISHED |
| evidence | PUBLISHED |

## Board

- B. Kristine Johnson: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2019-01-01. claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:8
- Linda M. Liau: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:10
- Lynnette C. Fallon: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2021-01-01. Committees: Audit Committee (chair). claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:11
- Matthew B. Klein: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2020-01-01. claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:12
- Timothy T. Richards: Director. Status: current. Independent: NOT_PUBLISHED. Since: 2014-01-01. claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:13
- Joseph M. Burnett: Chief Executive Officer, President and Director. Status: unknown. Independent: false. Since: NOT_PUBLISHED. Committees: President and Director (member). claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:9
- R. John Fletcher: Chairman of the Board. Status: unknown. Independent: true. Since: NOT_PUBLISHED. claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:7

## Committees

- Audit Committee (audit). Chair: Lynnette C. Fallon. Members: Lynnette C. Fallon (chair, current). committee_id=alpha:committee:clearpoint-neuro-inc:audit-committee
- President and Director (other). Chair: NOT_PUBLISHED. Members: Joseph M. Burnett (member, unknown). committee_id=alpha:committee:clearpoint-neuro-inc:president-and-director

## Executive leadership

- Danilo D'Alessandro: Chief Financial Officer [CFO]. Status: unknown. claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:14
- Jeremy L. Stigall: Chief Business Officer. Status: unknown. claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:15
- Joseph M. Burnett: Chief Executive Officer and President [CEO]. Status: unknown. claim_id=alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:16

## Governance events

- DIRECTOR_APPOINTED: Linda M. Liau seat on ClearPoint Neuro, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-25T04:46:33.007823+00:00. event_id=alpha:event:transition:1k34ulwf241k0
- DIRECTOR_APPOINTED: Lynnette C. Fallon seat on ClearPoint Neuro, Inc., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-25T04:46:33.007823+00:00. event_id=alpha:event:transition:wrlit510royw9
- DIRECTOR_APPOINTED: Matthew B. Klein seat on ClearPoint Neuro, Inc., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-25T04:46:33.007823+00:00. event_id=alpha:event:transition:1eutg1td39cun
- DIRECTOR_APPOINTED: B. Kristine Johnson seat on ClearPoint Neuro, Inc., effective 2019-01-01. Effective: 2019-01-01. Detected: 2026-10-25T04:46:33.007823+00:00. event_id=alpha:event:transition:g3b7ha195050y
- DIRECTOR_APPOINTED: Timothy T. Richards seat on ClearPoint Neuro, Inc., effective 2014-01-01. Effective: 2014-01-01. Detected: 2026-10-25T04:46:33.007823+00:00. event_id=alpha:event:transition:1udto2tg8qz45

## Scoped resources

- `alpha://company/clearpoint-neuro-inc` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record
- `alpha://company/clearpoint-neuro-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=identity
- `alpha://company/clearpoint-neuro-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=corporate-structure
- `alpha://company/clearpoint-neuro-inc/board` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=board
- `alpha://company/clearpoint-neuro-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=committees
- `alpha://company/clearpoint-neuro-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=leadership
- `alpha://company/clearpoint-neuro-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=ownership
- `alpha://company/clearpoint-neuro-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=financials
- `alpha://company/clearpoint-neuro-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=capital-structure
- `alpha://company/clearpoint-neuro-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=compensation
- `alpha://company/clearpoint-neuro-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=governance
- `alpha://company/clearpoint-neuro-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=shareholder-governance
- `alpha://company/clearpoint-neuro-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=audit
- `alpha://company/clearpoint-neuro-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=legal
- `alpha://company/clearpoint-neuro-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=risk
- `alpha://company/clearpoint-neuro-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=cyber
- `alpha://company/clearpoint-neuro-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=ai-governance
- `alpha://company/clearpoint-neuro-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=agents
- `alpha://company/clearpoint-neuro-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=ecosystem
- `alpha://company/clearpoint-neuro-inc/events` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=events
- `alpha://company/clearpoint-neuro-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=relationships
- `alpha://company/clearpoint-neuro-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=assessments
- `alpha://company/clearpoint-neuro-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record&section=evidence

## Role modules

- NOT_ASSERTED

## Attention

- NO_RECORDS_FOUND

## Committee data

- Claim alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit Committee","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:lynnette-c-fallon-clpt","name":"Lynnette C. Fallon"},"source_id":"governance_people_committees"}`

## Leadership

- R. John Fletcher: Chairman of the Board. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:650fcda28b34d776f9541c36a38de0cce9683860859f8f9c74a9aea1b636f503.
- B. Kristine Johnson: Director. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:8. Valid from: 2019-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2baedd844e0dd14b09867008ffc0a269b5edb5c56af7b41d2910ed9ef7a416a6.
- Joseph M. Burnett: Chief Executive Officer, President and Director. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:650fcda28b34d776f9541c36a38de0cce9683860859f8f9c74a9aea1b636f503.
- Linda M. Liau: Director. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:10. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2baedd844e0dd14b09867008ffc0a269b5edb5c56af7b41d2910ed9ef7a416a6.
- Lynnette C. Fallon: Director. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:11. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2baedd844e0dd14b09867008ffc0a269b5edb5c56af7b41d2910ed9ef7a416a6.
- Matthew B. Klein: Director. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:12. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2baedd844e0dd14b09867008ffc0a269b5edb5c56af7b41d2910ed9ef7a416a6.
- Timothy T. Richards: Director. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:13. Valid from: 2014-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:2baedd844e0dd14b09867008ffc0a269b5edb5c56af7b41d2910ed9ef7a416a6.
- Danilo D'Alessandro: Chief Financial Officer. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:14. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:650fcda28b34d776f9541c36a38de0cce9683860859f8f9c74a9aea1b636f503.
- Jeremy L. Stigall: Chief Business Officer. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:650fcda28b34d776f9541c36a38de0cce9683860859f8f9c74a9aea1b636f503.
- Joseph M. Burnett: Chief Executive Officer and President. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:650fcda28b34d776f9541c36a38de0cce9683860859f8f9c74a9aea1b636f503.

## Roles

- PUBLISHED

## Governance

- NOT_ASSERTED

## Board committees

- Audit Committee: Chair Lynnette C. Fallon; Members Lynnette C. Fallon (Chair). Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:committee_record:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f790365230bf4f38e039400ea9833c51462dfe27a33b4b69c10b1b206fbc25d8.

## Financials

- NOT_ASSERTED

## Workforce

- NOT_ASSERTED

## Market and index context

- PUBLISHED

## Legal Name

- ClearPoint Neuro, Inc.. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2832d9f177a0503df2976caf08ed244a3ed6a44f55058ddb3830b559b0fe7fc7.

## Entity Status

- Public listing published. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2832d9f177a0503df2976caf08ed244a3ed6a44f55058ddb3830b559b0fe7fc7.

## Published Fact

- US. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2832d9f177a0503df2976caf08ed244a3ed6a44f55058ddb3830b559b0fe7fc7.
- Healthcare. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:published_fact:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2832d9f177a0503df2976caf08ed244a3ed6a44f55058ddb3830b559b0fe7fc7.
- Medical - Devices. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:published_fact:6. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2832d9f177a0503df2976caf08ed244a3ed6a44f55058ddb3830b559b0fe7fc7.

## Committee Appointment

- Lynnette C. Fallon: chair, Audit Committee. Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:f790365230bf4f38e039400ea9833c51462dfe27a33b4b69c10b1b206fbc25d8.

## Security Listing

- CLPT (NASDAQ). Claim: alpha:claim:company:0ec501c5-0069-42c7-b1a3-e45364681e9f:security_listing:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:2832d9f177a0503df2976caf08ed244a3ed6a44f55058ddb3830b559b0fe7fc7.

## Coverage states

| Field | Value |
| --- | --- |
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |

## Public sources

- alpha:projection-evidence:2832d9f177a0503df2976caf08ed244a3ed6a44f55058ddb3830b559b0fe7fc7: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/clearpoint-neuro-inc).
- alpha:projection-evidence:document:650fcda28b34d776f9541c36a38de0cce9683860859f8f9c74a9aea1b636f503: [SEC DEF 14A 0001193125-26-151345](https://www.sec.gov/Archives/edgar/data/1285550/000119312526151345/clpt-20260410.htm).
- alpha:projection-evidence:document:2baedd844e0dd14b09867008ffc0a269b5edb5c56af7b41d2910ed9ef7a416a6: [DEF 14A clpt-20260410.htm](https://www.sec.gov/Archives/edgar/data/1285550/000119312526151345/clpt-20260410.htm).
- alpha:projection-evidence:f790365230bf4f38e039400ea9833c51462dfe27a33b4b69c10b1b206fbc25d8: [Audit Committee](https://www.sec.gov/Archives/edgar/data/1285550/000119312526151345/clpt-20260410.htm).

## Rights

| Field | Value |
| --- | --- |
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |

## Limitations

- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.

## Alternate representations

- [Canonical profile](https://registry.alpha.ac/companies/clearpoint-neuro-inc)
- [Public Markdown](https://registry.alpha.ac/companies/clearpoint-neuro-inc.md)
- [Public JSON](https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=record)
- [JSON-LD](https://registry.alpha.ac/api/public/companies/clearpoint-neuro-inc?format=jsonld)
- MCP resource: `alpha://companies/clearpoint-neuro-inc` at https://mcp.alpha.ac/mcp


## Connected governance records

Structured intelligence is not currently available. Existing published profile evidence remains accessible.

## Critical-risk oversight

Snapshot as of 2026-10-25T15:32:44.413903+00:00; recorded 2026-10-25T15:32:44.413903+00:00. Every published assignment for this snapshot is listed.
Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording.
An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.